Table 1 Clinical and radiologic characteristics of pituicytomas
From: Histologic, immunohistochemical, and molecular features of pituicytomas and atypical pituicytomas
Patient | Gender | Age at diagnosis (years) | Visual Symptoms | Hormonal Symptoms | Incidental finding | Size on imaging (cm) | Sellar | Supra-sellar | % of tumor resected | Follow-up (years) | Progression/Recurrence | Panhypopit-uitarism/DI | Deceased |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | M | 47 | N | Y | N | 3.1 (MRI) | Y | Y | 95% | 8.4 | N | Y | N |
2 | F | 41 | Y | Y | N | 1.9 (MRI) | Y | Y | – | 1.2 | N | Y | N |
3 | M | 64 | Y | N | N | 3.5 (MRI) | Y | Y | 70% | 3.8 | N | Y | N |
4 | M | 49 | N | Y | N | 1.0 (MRI) | N | Y | 30% | 2.8 | N | Y | N |
5 | F | 30 | Y | N | N | 1.7 (MRI) | Y | Y | GTR | 1.5 | N | Y | N |
6 | F | 48 | N | N | Y | 1.6 (MRI) | N | Y | GTR | 1.4 | N | Y | N |
7 | M | 76 | N | N | Y | 1.6 (MRI) | N | Y | GTR | 0.5 | N | Y | N |
8 | F | 30 | Y | Y | N | 1.8 (MRI) | Y | Y | GTR | – | – | – | – |
9 | M | 62 | N | N | Y | 1.3 (MRI) | Y | Y | 50% | N/A | N/A | N/A | Y |
10a | F | 59 | Y | N | N | 2.0 (MRI) | Y | Y | 60% | 10.1 | Y | Y | Y |
11a | M | 77 | Y | Y | N | 2.7 (CT) | Y | Y | 85% | 3.8 | N | Y | N |
1:2: 1 (M:F) | 53.0 ± 16.2 | 54.6% | 45.5% | 27.3% | 2.04 ± 0.8 | 72.7% | 100% | 79.0% ± 25.3% | 3.7 ± 3.3 | 90% | 100% | 20.0% |